Determining the impact of polymorphisms in the FKBP5 gene on genetic susceptibility to depression and their influence on the response to antidepressant medication could enable the prediction of treatment effectiveness and medication side effects for a patient prior to initiating treatment. Here, FKBP5 is linked to depressive symptom measurement.